Immuno-Oncology Program
The Immuno-Oncology Program defines the mechanisms by which tumors evade rejection by the immune system and develops strategies to thwart them. Key to the Program's success is the close integration of immuno-oncology clinical, translational, and basic scientists that facilitates rapid progression of novel immunotherapies from the bench to bedside.
